The Heel Enthesitis Scoring System (HEMRIS) represents a reliable enthesitis outcome measure for spondyloarthritis and psoriatic arthritis, according to study results recently published in The Journal of Rheumatology. This study included consensus on major pathology definitions and 3 scoring exercises on heel enthesitis. The working group for the Outcome Measure in Rheumatology (OMERACT) Magnetic Resonance…
CDC investigators assessed recent state-specific data on the prevalence of arthritis and, in doing so, observed an association between severe joint pain and physical inactivity in adults with arthritis.
In this post-hoc analysis, elevated C-reactive protein levels at baseline were associated with greater structural progression in patients with PsA who had an inadequate response to conventional synthetic DMARD and were treated with tofacitinib or adalimumab.
The outcome in this case is hypothesis-generating in that it suggests that the gut microbiome may play an etiologic role in psoriatic arthritis.
Physical functioning was found to be affected by factors including the presence of comorbidities, female sex, disease duration and activity in patients with psoriatic arthritis.
Real-life data support the validity of switching from reference etanercept to SB4 for most patients with psoriatic arthritis.
Intravenous golimumab was effective in reducing the signs and symptoms of active psoriatic arthritis in adult patients with sustained response through 1 year of treatment.
Early initiation of combination therapy with golimumab plus methotrexate doubled the number of patients achieving psoriatic arthritis remission compared with methotrexate alone.
Researchers examined the range of patient experiences with psoriasis and psoriatic arthritis to inform gaps in patient-centered care.
Investigators assessed the risk for atrial fibrillation and major adverse cardiovascular events potentially related to using ustekinumab vs tumor necrosis factor inhibitors in patients with psoriasis or psoriatic arthritis.
